Telehealth Company, Pelago, Raises Additional $58 Million in Venture Capital Funding
Virtual clinic, Pelago, raises $58 million for expansion in remote delivery of substance use disorder treatment.
Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.
New DNA Test Predicts Susceptibility to Opioid Addiction
The U.S. Food and Drug Administration has approved the use of a new DNA test to identify patients at risk of opioid use disorder.
Buprenorphine As an Emergency Treatment for Opioid Overdose
Training and equipping emergency medical personnel to administer buprenorphine is a money saver and a lifesaver.
How Does Delay Discounting Relate to Addiction?
Delay discounting is a measure of how much you have to reward a person to delay gratification. Two studies look at how it impacts addiction.
How the Demonization of Addiction Costs Municipalities Lives and Money
Due to stigma and moral hazard, many communities suffer more overdose deaths, lost income and unreimbursed costs.